TY - JOUR
T1 - Comparing Health-Care Providers' Perspectives on Complementary and Alternative Medicine in Childhood Cancer Between Netherlands and Indonesia
AU - Gunawan, Stefanus
AU - Arnoldussen, Marijn
AU - Gordijn, Maartje S.
AU - Sitaresmi, Mei N.
AU - van de Ven, Peter M.
AU - ten Broeke, Chloé A.M.
AU - Veerman, Anjo J.P.
AU - Mantik, Max
AU - Kaspers, Gertjan J.L.
AU - Mostert, Saskia
N1 - Publisher Copyright:
© 2015 Wiley Periodicals, Inc.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Background: Use of complementary and alternative medicine (CAM) is common among patients with childhood cancer. Health-care providers (HCP) should address this need properly. Geographical and cultural differences seem likely. This study explores perspectives on CAM of HCP involved in the care of children with cancer in Netherlands and Indonesia. Health beliefs, components of CAM, encouraging or discouraging CAM, and knowledge about CAM were assessed. Procedure: We conducted a cross-sectional study using semi-structured questionnaires at a Dutch and Indonesian academic hospital. Results: A total of 342 HCP participated: 119 Dutch (response rate 80%) and 223 Indonesian (response rate 87%). Chemotherapy can cure cancer according to more Dutch than Indonesian HCP (87% vs. 53% respectively, P<0.001). Combination of chemotherapy and CAM is the best way to cure cancer according to more Indonesian than Dutch HCP (45% vs. 25%, P<0.001). Dutch and Indonesian HCP recommend and discourage CAM use differently. Most Dutch (77%) and Indonesian HCP (84%) consider their knowledge about CAM to be inadequate (P=ns). Fewer Dutch doctors than other HCP want to learn more about CAM (51% vs. 76%, P=0.007), whereas there is no significant difference in eagerness to learn about CAM between Indonesian doctors (64%) and other HCP (72%). Conclusions: Indonesian HCP have more positive views about CAM than their Dutch colleagues. Both Dutch and Indonesian HCP consider their knowledge about CAM to be inadequate. Therefore, education programs about CAM tailored to the needs of HCP are recommended, knowing that CAM is used frequently.
AB - Background: Use of complementary and alternative medicine (CAM) is common among patients with childhood cancer. Health-care providers (HCP) should address this need properly. Geographical and cultural differences seem likely. This study explores perspectives on CAM of HCP involved in the care of children with cancer in Netherlands and Indonesia. Health beliefs, components of CAM, encouraging or discouraging CAM, and knowledge about CAM were assessed. Procedure: We conducted a cross-sectional study using semi-structured questionnaires at a Dutch and Indonesian academic hospital. Results: A total of 342 HCP participated: 119 Dutch (response rate 80%) and 223 Indonesian (response rate 87%). Chemotherapy can cure cancer according to more Dutch than Indonesian HCP (87% vs. 53% respectively, P<0.001). Combination of chemotherapy and CAM is the best way to cure cancer according to more Indonesian than Dutch HCP (45% vs. 25%, P<0.001). Dutch and Indonesian HCP recommend and discourage CAM use differently. Most Dutch (77%) and Indonesian HCP (84%) consider their knowledge about CAM to be inadequate (P=ns). Fewer Dutch doctors than other HCP want to learn more about CAM (51% vs. 76%, P=0.007), whereas there is no significant difference in eagerness to learn about CAM between Indonesian doctors (64%) and other HCP (72%). Conclusions: Indonesian HCP have more positive views about CAM than their Dutch colleagues. Both Dutch and Indonesian HCP consider their knowledge about CAM to be inadequate. Therefore, education programs about CAM tailored to the needs of HCP are recommended, knowing that CAM is used frequently.
KW - Complementary alternative medicine
KW - Health-care providers
KW - Perspectives
UR - http://www.scopus.com/inward/record.url?scp=84951570294&partnerID=8YFLogxK
U2 - 10.1002/pbc.25689
DO - 10.1002/pbc.25689
M3 - Article
C2 - 26274831
AN - SCOPUS:84951570294
SN - 1545-5009
VL - 63
SP - 118
EP - 123
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 1
ER -